Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Running

LOCAL-CAR Hydrogel-nanoparticle delivery platform for LOCALized CAR-M immunotherapy

Coordinator
Technische Universiteit Eindhoven, Netherlands
Runs
1 November 2026 to 30 April 2028
Status
Running
EU funding
€150k
Total cost
—
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101334969

What the project is doing

In the project's own words, from its summary on CORDIS.

LOCAL-CAR is a Proof-of-Concept project aimed at validating a modular hydrogel-based platform for localized mRNA immunotherapy, targeting peritoneal tumor burden in ovarian and colorectal cancer models. Building on ERC-funded technologies – ABGel and aNP-mRNA – the project integrates these into a single ABGel-mRNA system for sustained intraperitoneal immunotherapy. The platform will generate HER2-CAR-expressing macrophages (CAR-M) directly within the peritoneal cavity, enabling local anti-HER2-tumor activity.

The project objectives are: (1) optimize ABGel-mRNA formulations encoding HER2-CAR constructs and screen their ability to generate functional CAR-M in vitro; (2) evaluate in vivo CAR‑M induction and therapeutic efficacy in mouse ovarian and colorectal cancer models; (3) develop IP strategy and expand patent portfolio; (4) conduct market analysis and engage stakeholders in the emerging in vivo CAR therapy landscape; and (5) disseminate findings and build strategic partnerships.

Co-applicant BioTrip supports IP management, regulatory strategy, and commercialization. LOCAL-CAR addresses a critical unmet need in oncology and offers a scalable, biocompatible solution with broad translational potential in immunotherapy, autoimmune diseases, and vaccination.

Topics

Who is involved

OrganisationCityCountryRole
Technische Universiteit EindhovenEindhovenNetherlandsCoordinator
Bio-Trip B.v.Bosch En DuinNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI